Osteoarthritis: an update with relevance for clinical practice, Lancet, vol.377, pp.2115-2141, 2011. ,
Osteoarthritis: is oa a mechanical or systemic disease?, Nat Rev Rheumatol, vol.10, pp.515-521, 2014. ,
Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives, Osteoarthritis Cartilage, vol.23, pp.2027-2062, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01834450
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease, N Engl J Med, vol.350, pp.1387-97, 2004. ,
Lipid metabolism and osteoarthritis: lessons from atherosclerosis, Prog Lipid Res, vol.50, pp.133-173, 2011. ,
Mesenchymal stem cell treatments in rheumatology: a glass half full?, Nat Rev Rheumatol, vol.10, issue.2, pp.117-141, 2014. ,
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide, Blood, vol.101, pp.3722-3751, 2003. ,
Interferon-gamma-dependent inhibition of b cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus, Arthritis Rheum, vol.62, pp.2776-86, 2010. ,
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin e2, Blood, vol.111, pp.1327-1360, 2008. ,
Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism, Stem Cells, vol.25, pp.2025-2057, 2007. ,
Mesenchymal stem cells generate a cd4+cd25+foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells, Stem Cell Res Ther, vol.4, p.65, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-00836318
Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation, Blood Cells Mol Dis, vol.40, pp.25-32, 2008. ,
Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (prochymal) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study, Biol Blood Marrow Transplant, vol.17, pp.534-575, 2011. ,
Adult human mesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease, Biol Blood Marrow Transplant, vol.15, pp.804-815, 2009. ,
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase 2 study, Lancet, vol.371, pp.1579-86, 2008. ,
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus, Arthritis Rheum, vol.62, pp.2467-75, 2010. ,
Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients, Lupus, vol.19, pp.317-339, 2010. ,
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising crohn's disease, Gut, vol.60, pp.788-98, 2011. ,
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal crohn's disease: results of a phase 1 study, Gut, vol.59, pp.1662-69, 2010. ,
The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory t cells by human mesenchymal stem cells, Blood, vol.117, pp.4826-4861, 2011. ,
Adipose derived stem cells for regenerative therapy in osteoarticular diseases, Horm Mol Biol Clin Investig, vol.28, issue.3, pp.113-133, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01834269
Adipose mesenchymal stromal cell-based therapy for severe osteoarthritis of the knee: a phase 1 dose-escalation trial, Stem Cells Transl Med, vol.5, issue.7, pp.847-56, 2016. ,
Phase 1 trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia, Cytotherapy, vol.16, pp.245-57, 2014. ,
Validation study of womac: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee, J Rheumatol, vol.15, pp.1833-1873, 1988. ,
Omeract-oarsi initiative: osteoarthritis research society international set of responder criteria for osteoarthritis clinical trials revisited, Osteoarthritis Cartilage, vol.12, pp.389-99, 2004. ,
EuroFlow: resetting leukemia and lymphoma immunophenotyping basis for companion diagnostics and personalized medicine, Leukemia, vol.26, pp.1899-907, 2012. ,
Standardizing immunophenotyping for the human immunology project, Nat Rev Immunol, vol.12, pp.191-200, 2012. ,
Semi-automated and standardized cytometric procedures for multi-panel and multi-parametric whole blood immunophenotyping, Clin Immunol, vol.157, pp.261-76, 2015. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01380961
Clinical significance of monocyte heterogeneity, Clin Transl Med, vol.4, p.5, 2015. ,
cd19(+)cd24(hi)cd38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients, Immunity, vol.32, pp.129-169, 2010. ,
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights, Mol Cell Endocrinol, vol.335, pp.2-13, 2011. ,
The emerging safety profile of jak inhibitors in rheumatic disease, Nat Rev Rheumatol, vol.13, pp.234-277, 2017. ,
Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review, Osteoarthritis Cartilage, vol.21, pp.1465-73, 2013. ,
Mesenchymal stromal cells and immunomodulation: a gathering of regulatory immune cells, Cytotherapy, vol.18, pp.160-71, 2016. ,
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells, Lancet, vol.363, pp.1439-1480, 2004. ,
Alterations in the cellular immune compartment of patients treated with third-party mesenchymal stromal cells following allogeneic hematopoietic stem cell transplantation, Stem Cells, vol.31, pp.1715-1740, 2013. ,
Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring, Leukemia, vol.26, pp.1681-84, 2012. ,
Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation, Biol Blood Marrow Transplant, vol.21, pp.97-104, 2015. ,
Tgf-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to cd3 in overt autoimmune diabetes, Nat Med, vol.9, pp.1202-1208, 2003. ,
Multiple immuno-regulatory defects in type-1 diabetes, J Clin Invest, vol.109, pp.131-171, 2002. ,
The proportion of regulatory t cells in patients with rheumatoid arthritis: a meta-analysis, PLoS One, vol.11, p.162306, 2016. ,
Decreased cd200r expression on monocyte-derived macrophages correlates with th17/treg imbalance and disease activity in rheumatoid arthritis patients, Inflamm Res, vol.63, pp.441-50, 2014. ,
Subpopulations of regulatory t cells in rheumatoid arthritis, systemic lupus erythematosus, and behcet's disease, J Korean Med Sci, vol.27, pp.1009-1022, 2012. ,
Compromised function of regulatory t cells in rheumatoid arthritis and reversal by anti-tnf alpha therapy, J Exp Med, vol.200, pp.277-85, 2004. ,
Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the one study, Transplant Res, vol.2, p.17, 2013. ,
Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of cd5+ regulatory b cells producing interleukin 10, Leukemia, vol.29, pp.636-682, 2015. ,
Cd14(bright)cd16+ intermediate monocytes are induced by interleukin-10 and positively correlate with disease activity in rheumatoid arthritis, Arthritis Res Ther, vol.19, p.28, 2017. ,
The cd14(bright)cd16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the th17 cell population, Arthritis Rheum, vol.64, pp.671-77, 2012. ,
Monocyte activation is elevated in women with knee-osteoarthritis and associated with inflammation, bmi and pain, Osteoarthritis Cartilage, vol.26, pp.255-63, 2018. ,
Alterations to the frequency and function of peripheral blood monocytes and associations with chronic disease in the advanced-age, frail elderly, PLoS One, vol.9, p.104522, 2014. ,